[New therapy for Peyronie's disease: superoxide dismutase by ionization. Comparison with an earlier classical series].
Due to the poor results obtained in the treatment of Peyronie's disease by ionophoresis and ultrasound, using the classical buffer solution of the cortisone thiomucase type, the authors have experimented ionophoresis with a new product: orgoteine a dismutase superoxide. Austrian authors have already demonstrated the value of this product. Its mechanism of action is still uncertain but it has an experimentally well demonstrated antiinflammatory activity. The good results are obvious not only on the pain, but also on the induration and incurvation, permitting the resumption of sexual intercourse in more than 75% of cases.
Vergès
J
J
Centre Chirurgical et Urologique, Hôpital Gouin, Clichy.
Chateau
A
A
D005966:Glucuronidase / Q000627:therapeutic use; D006801:Humans; D007478:Iontophoresis; D008190:Lyases / Q000627:therapeutic use; D008297:Male; D010411:Penile Induration / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D013482:Superoxide Dismutase / Q000008:administration & dosage / Q000627:therapeutic use*; D014221:Triamcinolone / Q000627:therapeutic use; D014464:Ultrasonic Therapy
D014221:Triamcinolone; C021812:mucopolysaccharidase; D013482:Superoxide Dismutase; D005966:Glucuronidase; D008190:Lyases
Nouveau traitement de la maladie de La Peyronie: la superoxyde dismutase par ionisations. Comparaison avec une série ancienne classique.